Projecting the need for gynecologic oncologists for the next 40 years

Obstetrics and Gynecology

Volumn 116, Issue 6, 2010, Pages 1366-1372

  Wallace, Amy H ^b   Havrilesky, Laura J ^a   Valea, Fidel A ^b   Barnett, Jason C ^b   Berchuck, Andrew ^b   Myers, Evan R ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ADULT; ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; DEMOGRAPHY; ENDOMETRIUM CANCER; FEMALE; HUMAN; MALE; MEDICAL EDUCATION; MEDICAL SOCIETY; MEDICAL SPECIALIST; OBESITY; OVARY CANCER; POPULATION; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SEX RATIO; UNITED STATES; UTERINE CERVIX CANCER; VACCINATION; VAGINA CANCER; VULVA CANCER; WART VIRUS;

FEMALE; FORECASTING; GENITAL NEOPLASMS, FEMALE; GYNECOLOGY; HUMANS; MALE; MEDICAL ONCOLOGY; MIDDLE AGED; POPULATION DYNAMICS; RETIREMENT; UNITED STATES;

EID: 78650166448     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3181fc3a22     Document Type: Article

References (18)

1. Press Release for 2008 National Projections. Available at: www.census.gov/Press-Release/www/releases/archives/ population/012496.html. Retrieved May 26, 2009.
2. Heron M, Hoyert DL, Murphy SL, Xu J, Kochanek KD, Tejada-Vera B. Deaths: final data for 2006. Natl Vital Stat Rep 2009;57:1-134.
3. U.S. Census Bureau. Projected population by single year of age, sex, race, and Hispanic origin for the United States: July 1, 2000 to July 1 2050. Washington, DC: US Census Bureau; 2008.
4. Surveillance, Epidemiology and End Results (SEER) Program. SEER*Stat Database, November 2007 Sub (1973-2005), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, Released April 2008, based on the November 2007 submission. Available at: www.seer. cancer.gov. Retrieved September 15, 2009.
5. Clifford GM, Smith JS, Plummer M, Muñoz N, Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003;88:63-73.
6. Society of Gynecologic Oncologists 2005 Practice Survey. Prepared by Smith Bucklin Corporation-Market Research & Statistic Group. Chicago (IL): Society of Gynecologic Oncologists; 2006.
7. Leadley J. Women in U.S. academic medicine: statistics and benchmarking report, 2008-2009. Washington, DC: American Association of Medical Colleges; 2009.
8. US Life Tables 2004. Abridged life table for the total population, 2006. National Vital Statistics Reports, Volume 56, Number 9. Available at: www.cdc.gov/nchs/data/nvsr/ nvsr56/nvsr56-09.pdf. Retrieved May 26, 2009.
9. Wang Y, Beydoun MA, Liang L, Caballero B, Kumanyika SK. Will all Americans become overweight or obese? Estimating the progression and cost of the US obesity epidemic. Obesity 2008;16:2323-30.
10. Bjørge T, Engeland A, Tretli S, Weiderpass E. Body size in relation to cancer of the uterine corpus in 1 million Norwegian women. Int J Cancer 2007;120:378-83.
11. Carney ME, Lancaster JM, Ford C, Tsodikov A, Wiggins CL. A population-based study of patterns of care for ovarian cancer: who is seen by a gynecologic oncologist and who is not? Gynecol Oncol 2002;84:36-42.
12. Díaz-Montes TP, Zahurak ML, Giuntoli RL 2nd, Gardner GJ, Bristow RE. Uterine cancer in Maryland: Impact of surgeon case volume and other prognostic factors on short-term mortality. Gynecol Oncol 2006;103:1043-7.
13. Bristow RE, Zahurak ML, Diaz-Montes TP, Giuntoli RL, Armstrong DK. Impact of surgeon and hospital ovarian cancer surgical case volume on in-hospital mortality and related short-term outcomes. Gynecol Oncol 2009;115:334-8.
14. Im SS, Gordon AN, Buttin BM, Leath CA 3rd, Gostout BS, Shah C, et al. Validation of referral guidelines for women with pelvic masses. Obstet Gynecol 2005;105:35-41.
15. Bauch CT, Li M, Chapman G, Galvani AP. Adherence to cervical screening in the era of human papillomavirus vaccination: how low is too low? Lancet Infect Dis 2010;10:133-7.
16. Regan DG, Philp DJ, Hocking JS, Law MG. Modelling the population-level impact of vaccination on the transmission of human papillomavirus type 16 in Australia. Sex Health 2007; 4:147-63.
17. Kulasingam SL, Myers ER. Potential health and economic impact of adding a human papillomavirus vaccine to screening programs. JAMA 2003;290:781-9.
18. Kulasingam SL, Pagliusi S, Myers E. Potential effects of decreased cervical cancer screening participation after HPV vaccination: an example from the U.S. Vaccine 2007;25:8110-3.